These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9693974

  • 1. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
    Dick AD, Duncan L, Hale G, Waldmann H, Isaacs J.
    J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
    Dick AD, McMenamin PG, Körner H, Scallon BJ, Ghrayeb J, Forrester JV, Sedgwick JD.
    Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
    [Abstract] [Full Text] [Related]

  • 3. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats.
    Ramanathan S, de Kozak Y, Saoudi A, Goureau O, Van der Meide PH, Druet P, Bellon B.
    J Immunol; 1996 Sep 01; 157(5):2209-15. PubMed ID: 8757348
    [Abstract] [Full Text] [Related]

  • 4. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
    Laliotou B, Duncan L, Dick AD.
    J Autoimmun; 1999 May 01; 12(3):145-55. PubMed ID: 10222024
    [Abstract] [Full Text] [Related]

  • 5. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, Kitamura M, Ohno S, Onoé K.
    J Leukoc Biol; 2006 Jun 01; 79(6):1193-201. PubMed ID: 16574770
    [Abstract] [Full Text] [Related]

  • 6. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE, Mahdi RM, Nussenblatt RB, Gery I, Caspi RR.
    J Immunol; 1993 Aug 01; 151(3):1627-36. PubMed ID: 8393049
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance?
    Sun B, Sun SH, Chan CC, Caspi RR.
    Exp Eye Res; 2000 Apr 01; 70(4):493-502. PubMed ID: 10865998
    [Abstract] [Full Text] [Related]

  • 8. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.
    Robertson MJ, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2250-7. PubMed ID: 12091424
    [Abstract] [Full Text] [Related]

  • 9. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).
    Dick AD, Forrester JV, Liversidge J, Cope AP.
    Prog Retin Eye Res; 2004 Nov 01; 23(6):617-37. PubMed ID: 15388077
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G, Silver PB, Rizzo LV, Chan CC, Wiggert B, Mastorakos G, Caspi RR.
    Invest Ophthalmol Vis Sci; 1996 Oct 01; 37(11):2211-8. PubMed ID: 8843907
    [Abstract] [Full Text] [Related]

  • 11. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
    Yotsukura J, Huang H, Singh AK, Shichi H.
    Cell Immunol; 1997 Dec 15; 182(2):89-98. PubMed ID: 9514702
    [Abstract] [Full Text] [Related]

  • 12. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
    Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B.
    Int Immunopharmacol; 2003 Oct 15; 3(10-11):1457-65. PubMed ID: 12946442
    [Abstract] [Full Text] [Related]

  • 13. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis.
    Robertson M, Liversidge J, Forrester JV, Dick AD.
    Invest Ophthalmol Vis Sci; 2003 Jul 15; 44(7):3034-41. PubMed ID: 12824249
    [Abstract] [Full Text] [Related]

  • 14. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response.
    Caspi RR, Silver PB, Chan CC, Sun B, Agarwal RK, Wells J, Oddo S, Fujino Y, Najafian F, Wilder RL.
    J Immunol; 1996 Sep 15; 157(6):2668-75. PubMed ID: 8805672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis.
    Keino H, Watanabe T, Sato Y, Okada AA.
    Br J Ophthalmol; 2010 Jun 15; 94(6):802-7. PubMed ID: 19965837
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
    Kohno H, Sakai T, Saito S, Okano K, Kitahara K.
    Exp Eye Res; 2007 Mar 15; 84(3):569-76. PubMed ID: 17208229
    [Abstract] [Full Text] [Related]

  • 20. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
    Usui Y, Akiba H, Takeuchi M, Kezuka T, Takeuchi A, Hattori T, Okunuki Y, Yamazaki T, Yagita H, Usui M, Okumura K.
    Eur J Immunol; 2006 Nov 15; 36(11):3071-81. PubMed ID: 17039566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.